ライフサイエンスコーパス: specific antibody

1 t commercial microelectrodes with an E. coli specific antibody.

2 lytes can be detected by simply changing the specific antibody.

3 ructures, as revealed by the use of a G4 DNA-specific antibody.

4 gene expression could be neutralized by TLR2-specific antibodies.

5 ion of ferritin immunosensor, using ferritin specific antibodies.

6 Caco-2 IECs using HIF-1alpha- or HIF-2alpha-specific antibodies.

7 ompanied by high serum levels of autoantigen-specific antibodies.

8 ocol biopsy and development of de novo donor-specific antibodies.

9 ntributing to the reduced ability to produce specific antibodies.

10 tokine/chemokine upregulation and SARS-CoV-2-specific antibodies.

11 es that were immunoprecipitated with complex-specific antibodies.

12 ely used for the detection of proteins using specific antibodies.

13 infected animals and dependent in part on PC-specific antibodies.

14 ions between innate effector cells and virus-specific antibodies.

15 sed using lipopolysaccharide (LPS) O antigen-specific antibodies.

16 lei, or Burkholderia mallei develop O-glycan-specific antibodies.

17 out the protective effect of breast milk RSV-specific antibodies.

18 is critical for neutralization by domain III-specific antibodies.

19 eutralizing activity is attributable to ZIKV-specific antibodies.

20 allergies through the production of allergen-specific antibodies.

21 ing activity and are less potent than strain-specific antibodies.

22 despite the induction of high levels of CSP-specific antibodies.

23 n by synergy with effector T cells and virus-specific antibodies.

24 design method for the discovery of oligomer-specific antibodies.

25 to germinal center B cells and secrete donor-specific antibodies.

26 unogen dose, influence the elicitation of V2-specific antibodies.

27 measure the antiviral activity of SARS-CoV-2-specific antibodies.

28 antially increase the elicitation of antigen-specific antibodies.

29 raditional FXM results are missing HLA donor-specific antibody 36.2% of the time based on the DSA-FXM

30 haperone protein prM, unlike most flavivirus-specific antibodies(4).

31 taO binding, which was blocked by the PrP(C)-specific antibody 6D11.

32 (IRI) predisposes to the formation of donor-specific antibodies, a factor contributing to chronic re

33 Using L. tropica specific antibody (Ab)-mediated phagocytosis assays, we

34 Engineering sequence-specific antibodies (Abs) against phosphotyrosine (pY) m

35 The trimer- and pentamer-specific antibodies acted in a synergistic fashion to ne

36 We analyzed the risk of de novo donor-specific antibodies, acute rejection, or death-censored

37 be used as a peptide antigen to detect FMDV-specific antibodies against all types of the virus.

38 nduced immune responses with the presence of specific antibodies against HCMVpp65(422-439) and TAF9(1

39 ment for large amounts of starting material, specific antibodies against proteins of interest, and/or

40 Low levels of specific antibodies against S pneumoniae were found in 1

41 ication of serum immunoglobulin (Ig) levels, specific antibodies against Streptococcus pneumoniae, an

42 The sensor consisted of two LipL32-specific antibodies: an unlabeled capture primary antibo

43 Two cases had durable ZIKV-specific antibodies and 2 cases had ZIKV antibodies at s

44 d with a bat isolate of MARV, we use species-specific antibodies and an immune gene probe array (Nano

45 uction of serological assays targeting virus-specific antibodies and antigens has been effective in i

46 l tolerance was studied by measuring Cyp c 1-specific antibodies and cellular responses by ELISA, bas

47 in this model was linked to production of GP-specific antibodies and lower viral load.

48 the genome as they occur, do not require TF-specific antibodies and offer the potential for unique a

49 luated by immunoblotting using five allergen-specific antibodies and patients' serum followed by mass

50 cipitation, are limited by requirement of TF-specific antibodies and provide only end-point snapshots

51 Using immunoblotting with CLCA1-specific antibodies and recombinant proteins, we observe

52 Using specific antibodies and riboprobes, we found that Kp neu

53 The groups had similar numbers of donor-specific antibodies and serious adverse events.

54 In this report, we developed Tc_5171 specific antibodies and showed that the native protein w

55 18 non-HLA antigens synergize with HLA donor-specific antibodies and significantly increase the odds

56 species from Namibia for the presence of IAV-specific antibodies and tested whether host phylogeny, s

57 d in vitro utilizing HLA-A*02:01/HBV epitope-specific antibodies and the corresponding CD8(+) T cells

58 The amount of CHIKV-specific antibodies and their binding avidity and cross-

59 ssentially all patients displayed SARS-CoV-2-specific antibodies and virus-neutralization capacity wi

60 cine due to the broad availability of highly specific antibodies and well-established bioconjugation

61 umab displayed significantly decreased donor-specific antibodies and, on prolonged treatment, modulat

62 Here, we have developed a p120-3 isoform-specific antibody and analyzed the p120-3 localization r

63 nal center (GC) responses to control antigen-specific antibody and B cell memory.

64 erance, characterized by lack of parvalbumin-specific antibody and cellular responses.

65 ion of ReACT for efficient, stable, and site-specific antibody and protein bioconjugation to native o

66 oimmune events (development of de novo donor specific antibody and/or biopsy proven rejection) and in

67 reduced compared to influenza- and pertussis-specific antibodies, and cord titers and functional acti

68 almette-Guerin (BCG) scar, presence of donor-specific antibody, and KTR group were independent factor

69 The described bioplatform relies on a specific antibody (anti-5-hmC), further conjugated with

70 3 (CDR3), which is responsible for imparting specific antibody-antigen interactions.

71 Plasmodium parasite-specific antibodies are critical for protection against

72 Assays to detect virus-specific antibodies are important to understand the prev

73 ization, and their conjugation with bacteria-specific antibodies are presented as well as proof-of-co

74 onor kidney transplants with preformed donor-specific antibodies are reported.

75 age, no BCG vaccination, and positive donor-specific antibody are also positive predictors for LTBI.

76 equent studies identifying the level of V1V2-specific antibodies as a correlate of reduced infection

77 of any blood-circulating protein using their specific antibodies as recognition elements.

78 Tetanus toxoid (TT)-specific antibody avidity was increased in APTB cases in

79 rough product, Ago1x, could be detected by a specific antibody both in vitro and in vivo.

80 ) that distinguishes HLA class I or II donor-specific antibody bound to HLA antigens on the donor cel

81 s linked not only with the presence of MAV-1-specific antibodies but also with a better recruitment o

82 ated with transient production of SARS-CoV-2-specific antibodies but may stimulate mucosal SARS-CoV-2

83 ssess dengue serology-status, we used dengue-specific antibodies by means of lateral-flow rapid test

84 orrelative association between IRI and donor-specific antibodies by using humanized models and patien

85 anti-HLA-total IgG, IgG3 and IgG4, and donor-specific antibody by Luminex assay.

86 We also demonstrated that waning of EEHV1-specific antibodies can occur in the first 2 years of li

87 ar of AIT, suggesting that dominant allergen-specific antibody clones remained as important contribut

88 evaluate gut microbiota composition and taxa-specific antibody coating of the gut microbiota in 15 sI

89 pment and assessment of a Sudan virus (SUDV)-specific antibody cocktail.

90 nked to preexisting local and systemic EHV-1-specific antibodies combined with rapidly increasing int

91 a two times or greater increase in serotype-specific antibody compared with baseline.

92 cryoEM) studies of B41 in complex with a B41-specific antibody complex elucidate the molecular basis

93 ral therapy (ART) regimens in infancy, HIV-1-specific antibody concentrations are associated with vir

94 reases in morbidity and decreases in measles-specific antibody concentrations before and after vaccin

95 nation with GMZ2, although baseline, vaccine-specific antibody concentrations were associated with pr

96 Baseline, vaccine-specific antibody concentrations were associated with pr

97 clear that VCA recipients can develop donor-specific antibodies, conclusions made in solid organ tra

98 The correlation of HIV-specific antibody-dependent cellular cytotoxicity (ADCC)

99 ing with an HIV-1 Env vaccine increased C1C2-specific antibody-dependent cellular cytotoxicity potenc

100 PPD-specific isotype/subclass, PPD-specific antibody-dependent phagocytosis, cellular cytot

101 /1.73 m (HR, 2.61; P = 0.011), de novo donor-specific antibody development (HR, 4.09; P < 0.001) and

102 iability of tacrolimus trough, de novo donor-specific antibody development, cytochrome P450 3A5 genot

103 Development of de novo donor-specific antibodies (dnDSA) has detrimental effects on g

104 e been associated with risk of de novo donor-specific antibodies (dnDSA).

105 (15.9%) developed anti-VA de novo HLA donor-specific antibodies (dnDSAs) at a median time after tran

106 These findings describe a glycan-specific antibody-drug conjugate that establishes polySi

107 The importance of donor-specific antibodies (DSA) after liver transplantation (L

108 lyze the impact of low-level preformed donor-specific antibodies (DSA) against an RMM on transplant o

109 Donor-specific antibodies (DSA) against HLA and non-HLA antige

110 increased risk for the development of donor-specific antibodies (DSA) and antibody-mediated rejectio

111 and to analyze their relationship with donor-specific antibodies (DSA) and histological phenotype.

112 ating factor (BAFF) is associated with donor-specific antibodies (DSA) and poorer outcomes after rena

113 lectively depleted mature PC producing donor-specific antibodies (DSA) and reduced DSA, when administ

114 Donor-specific antibodies (DSA) are putatively associated with

115 ion (AMR) driven by the development of donor-specific antibodies (DSA) directed against mismatched do

116 Donor-specific antibodies (DSA) play a major role in antibody-

117 posed to rapid increases in high-titer donor-specific antibodies (DSA) that are most often generated

118 ility to reduce the incidence of these donor-specific antibodies (DSA), but its mechanism is suboptim

119 ches were achieved against 3, 6, and 8 donor-specific antibodies (DSA), including those that were his

120 n and may act synergistically with HLA donor-specific antibodies (DSA).

121 notype with the development of de novo donor-specific antibody (DSA) after kidney transplantation.

122 and immunohistochemical analysis, and donor- specific antibody (DSA) characterization with their curr

123 Reduction in donor-specific antibody (DSA) has been associated with improve

124 formation exists about outcomes of HLA donor-specific antibody (DSA) negative (DSA-) microvascular in

125 nderlying the induction of deleterious donor-specific antibody (DSA) responses remain poorly understo

126 atment of subclinical AMR based on the donor-specific antibody (DSA) testing may result in better out

127 ave described its use in patients with donor-specific antibody (DSA).

128 FR], proteinuria, time posttransplant, donor-specific antibody [DSA]) and molecular and histologic fe

129 De novo donor-specific antibodies (DSAs) are associated with antibody-

130 molecular mismatch to predict de novo donor-specific antibodies (DSAs) during the first year of tran

131 Donor-specific antibodies (DSAs) have a strong negative correl

132 ive memory T and B cells and preformed donor-specific antibodies (DSAs) have all been implicated in a

133 Binding of donor-specific antibodies (DSAs) to kidney allograft endotheli

134 Notably, CD277-specific antibodies elicit coordinated restoration of al

135 sed human plasma, and functionalization with specific antibodies enables quantification of anti-inter

136 of the most potently neutralizing flavivirus-specific antibodies ever isolated.

137 , we demonstrate higher levels of SARS-CoV-2-specific antibody features of these family members compa

138 lates CCT activity, we developed phosphosite-specific antibodies for pS319 and pY359+pS362 at the N-

139 Finally, using a specific antibody for integrin beta2, we inhibited cell

140 dd-cfDNA patients (P = .004), de novo donor-specific antibody formation was seen in 40% (17/42) vs 2

141 cells in allograft tissues to promote donor-specific antibody formation.

142 In this study, we developed a CD44-specific antibody fragment and evaluated it for imaging

143 II) from Pseudomonas aeruginosa and a cancer-specific antibody fragment, has been developed to manage

144 analyze this response by isolating 806 RSV F-specific antibodies from paired adenoid and peripheral b

145 Virus-specific antibodies from recovered persons are often the

146 his study, we isolated and characterized HIV-specific antibodies from the mother of an infant whose t

147 oprecipitation with damage- or repair factor-specific antibodies from the non-chromatin fraction.

148 To determine PvMSP1P-19-specific antibody function and B-cell epitopes in vivax

149 Pre-F-specific antibody geometric mean titers and median frequ

150 their low abundance, and the lack of highly specific antibodies, GPCRs are still challenging to stud

151 duced anti-HLA antibodies and anti-HLA donor-specific antibodies in a nonhuman primate model and in t

152 luten-related signs and symptoms and disease-specific antibodies in addition to enteropathy.

153 frequently identified high levels of CSF EV-specific antibodies in AFM compared with controls, provi

154 ng to date, the seroprevalence of SARS-CoV-2-specific antibodies in different populations has remaine

155 ion on transfected whole cells yielded hCD20-specific antibodies in four rounds of panning.

156 dylinositol (GPI1) for the detection of GPI1-specific antibodies in human sera.

157 sence of coronavirus disease 2019 (COVID-19)-specific antibodies in human serum and plasma.

158 Half-lives of RSV-specific antibodies in infants approximated 40 days.

159 Serological testing to evaluate antigen-specific antibodies in plasma is generally performed by

160 highly expressed IL-18R1 and promoted donor-specific antibodies in response to IL-18 in vivo.

161 mechanism necessary to produce robust HIV-1-specific antibodies in rhesus macaques.

162 RS-CoV-2 S and authentic SARS-CoV-2 by spike-specific antibodies in these antisera is highly correlat

163 of anti-MHC class II (but not class I) donor-specific antibodies, increased donor-reactive T cells, a

164 ly due to blocking of these epitopes by stem-specific antibodies induced by the first immunization.

165 The antigen-specific antibodies induced by TT3-nanoparticles and NAS

166 andidate, dl5-29, leads to transfer of virus-specific antibodies into the neonatal circulation and pr

167 supporting development of B cells expressing specific antibody isotypes, or T effector cells, which a

168 These new antisera, alongside other specific antibodies, labeled sections from control, hACh

169 ity to H pylori proteins, as well as protein-specific antibody level, with odds of CRC was determined

170 eral blood samples and determined SARS-CoV-2-specific antibody levels against the S-protein, its RBD-

171 daratumumab had significantly reduced donor-specific antibody levels compared with untreated control

172 ferometry for the rapid detection of antigen-specific antibody levels in plasma samples, and demonstr

173 uencies in blood and BAL correlated with SIV-specific antibody levels in rectal secretions and with S

174 PAMVAC-specific antibody levels were highest with PAMVAC-GLA-SE

175 Allergen-specific antibody levels were measured in streptavidin I

176 zes germinal center responses, reduces donor-specific antibody levels, and prolongs allograft surviva

177 we observed no consistent difference in type-specific antibody levels.

178 nalysis reveals differential patterns of HEV-specific antibody lineages and highlights the necessity

179 tom severity correlating directly with virus-specific antibody magnitude.

180 , as well as the easy substitution of target-specific antibodies make this concept applicable to a la

181 same cohort (cutoff value, 40 mg of antigen-specific antibodies [mgA]/liter).

182 s in chemical and enzymatic methods for site-specific antibody modification that result in the genera

183 from the serologic testing of blood for EBOV-specific antibodies, molecular testing for EBOV in blood

184 ior rejection (n=76, 62%), presence of donor-specific antibodies (n=69, 57%), and prior peripartum ca

185 matic treatments-that is using more and more specific antibodies neutralizing particular immune pathw

186 Binding of AQP4-specific antibodies (NMO-IgG) triggers activation of the

187 This strategy of selection of specific antibody nucleotides by immunogen design can be

188 Here, we examined 12 murine erythrocyte-specific antibodies of different specificity and subtype

189 Donor-specific antibodies of the IgG isotype are measured rout

190 trajectories remain poorly defined, pathogen-specific antibodies often point to immunological mechani

191 The negative role of HLA class II donor-specific antibody on graft outcome is well recognized.

192 marrow for years or even decades, producing specific antibodies or even experiencing regeneration wi

193 alter protein's ability to be recognised by specific antibodies or the CpGODN to function as a TLR9

194 r own survival, while VEGF neutralization by specific antibodies or traps drastically reduced the RGC

195 Finally, the addition of a CA-specific antibody or PF74 inhibited PIC-associated integ

196 Neutralization of Rap1 by specific antibody or pharmacological inhibition of Rap1

197 class II anti-human leukocyte antigen donor-specific antibodies (P=0.004), and acute cellular reject

198 Using a Ser68 phospho-specific antibody (P-Panx3) revealed Panx3 was phosphory

199 Donor-specific antibodies play a major role in antibody-mediat

200 cific and qualitative features of SARS-CoV-2-specific antibodies point to differences in disease traj

201 al glycosylation was observed across antigen-specific antibody populations.

202 d 20 kidney transplant recipients with donor-specific, antibody-positive ABMR >=365 days post-transpl

203 rejection episode, malignancy, de novo donor specific antibody, posttransplant diabetes (PTD), cardia

204 MIS-C had reduced breadth of anti-SARS-CoV-2-specific antibodies, predominantly generating IgG antibo

205 si and other malaria species was measured by specific antibody prevalence and infection detected usin

206 C were able to bind a prefusion conformation-specific antibody prior to cell disruption, indicating t

207 e infection by differentiating into pathogen-specific antibody-producing effector plasmablasts/plasma

208 C1-INH may decrease sensitization and donor-specific antibody production and might improve outcomes

209 tissue in conjunction with increased antigen-specific antibody production.

210 thermore, this enriched immunodominant spike-specific antibody profile in convalescents was confirmed

211 ccine and infection-elicited alpha-hemolysin-specific antibodies protect against S. aureus-induced de

212 Passively acquired maternal GBS-specific antibodies protect newborns from early-onset di

213 logical assay for quantitation of SARS-CoV-2-specific antibodies proved to be robust and can be condu

214 hage recruitment, suggesting augmented donor-specific antibodies, rather than T cells, increase glome

215 patients do not respond or experience donor-specific antibody rebound, highlighting the diversity of

216 Aggregation-specific antibodies recognize sequences that display a s

217 correlate of HIV-1 risk, we examined antigen-specific antibody recruitment of Fcgamma receptors (Fcga

218 The detection of pathogen-specific antibodies remains a cornerstone of clinical di

219 e-induced Env constant region 1 and 2 (C1C2)-specific antibody repertoire.

220 data point toward a contribution of epitope-specific antibody repertoires to the pathogenesis of egg

221 ell-mediated immunity, P27A induced a marked specific antibody response able to recognize TEX1 in inf

222 ion significantly increased the level of the specific antibody response induced by our epicutaneous P

223 The HSV-specific antibody response was not diminished, but frequ

224 that translates into a more robust HHV-6A/B-specific antibody response.IMPORTANCE HHV-6A and -6B are

225 virus shedding, and developed a strong virus-specific antibody response; importantly, they were prote

226 owed a higher prevalence and diversity of HA-specific antibody responses against 11 different subtype

227 Ig), Qa-1 mutant mice developed robust donor-specific antibody responses and accelerated heart graft

228 in vitro and their vaccine efficacy (antigen-specific antibody responses and IFN-gamma production) an

229 Articles reporting GAS emm-type or emm-type-specific antibody responses associated with rheumatic fe

230 10th percentile) responders based on vaccine-specific antibody responses following vaccination were f

231 cal assays that allow the detection of viral specific antibody responses in COVID-19 patients or reco

232 Here we measured the HIV-1-specific antibody responses in female New Zealand White

233 nitude and affinity of neutralizing, antigen-specific antibody responses in mice immunized with dengu

234 g to affinity mature these types of IgG C1C2-specific antibody responses may be one method by which t

235 Pathogen-specific antibody responses need to be tightly regulated

236 route are able to induce serum antigen-specific antibody responses similar to those induced by

237 Yet little is known about the specific antibody responses toward each site in terms of

238 l BPZE1 vaccinees showed robust B. pertussis-specific antibody responses with regard to significant i

239 del, we quantified how morphine alters virus-specific antibody responses, and how this alteration aff

240 existing flu vaccines elicit strong antigen-specific antibody responses, they fail to provide effect

241 nformational manner for induction of antigen-specific antibody responses.

242 cific T cell responses correlated with spike-specific antibody responses.

243 ar immune system in addition to induction of specific antibody responses.

244 early help to accelerate hemagglutinin (HA)-specific antibody responses.

245 munogold electron microscopy using a TBC1D24-specific antibody revealed that TBC1D24 is associated wi

246 HPV-specific antibody secreting cells (ASCs) were present in

247 HBsAg-specific antibody-secreting cells (ASCs) response was no

248 howed induction of higher levels of envelope-specific antibody-secreting cells and memory B cells, hi

249 Serum antibody levels and the number of HSV-specific antibody-secreting cells in secondary lymphoid

250 Using a PANX1 Tyr(198)-specific antibody, SFK inhibitors, SRC knockdown, temper

251 We demonstrate that using cGMP-specific antibody, sGC or PDE activity and the effect of

252 Allergen-specific antibodies, splenocyte cytokine production and

253 The robust RBD-specific antibody, T cell and favourable cytokine respon

254 nnective tissue growth factor, CTGF) using a specific antibody (termed FG-3019 or pamrevlumab) reduce

255 showed positive staining for all phospho-tau-specific antibodies tested, similar to the pattern seen

256 piratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody tests are increasingly being used to e

257 rminal sialic acids linked alpha-2,3, but P1-specific antibodies that blocked M. pneumoniae hemadsorp

258 urally produce high quantities of the glycan-specific antibodies that can be protective against infec

259 significant decrease in class 1 and 2 donor-specific antibodies that led to clinical improvement of

260 utdown, the detection of both SARS-CoV-2 and specific antibodies that recognize the virus will become

261 entify a combination of antigen- and epitope-specific antibodies that using 3- to 15-month or 2- to 3

262 permit transplantation via lowering of donor-specific antibodies, the B cell-response axis from germi

263 absence of C4d staining or detectable donor-specific antibodies; the potential value of molecular di

264 ell as tools to explore the development of a specific antibody therapy for astrovirus disease.

265 To date, pathogen-specific antibody therapy has primarily been developed f

266 RTS,S-induced NPNA-specific antibody titer and avidity have been associated

267 emarkably high and dose-dependent SARS-CoV-2 specific antibody titers in mouse sera, as well as robus

268 d sex differences in viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines and blood-cel

269 Here, we describe a new assay that uses GP-specific antibodies to measure GP thermostability under

270 Using newly developed phosphosite-specific antibodies to the NOP receptor, we found that a

271 Using specific antibodies to the NSPs along with our labeled i

272 tralizing human immunodeficiency virus (HIV)-specific antibody to HIV-infected persons leads to the d

273 We have developed a specific antibody to Pcdh-gammaC4 to reveal the expressi

274 However, SARS-CoV-2-specific antibody transfer was significantly reduced com

275 le of influenza-, pertussis-, and SARS-CoV-2-specific antibodies transferred across the placenta.

276 o analyze the development of HLA transfusion-specific antibodies (TSA) to blood donors of transfusion

277 ipant who had PBMCs which produced anti-EBOV-specific antibodies upon stimulation.

278 nfluenza, evades recognition by these strain-specific antibodies via the emergence of new mutant stra

279 V infection is based on the detection of HEV-specific antibodies, viral RNA, and/or antigen (Ag).

280 However, the reduction in donor-specific antibodies was not maintained because all recip

281 e-chain variable region (scFv) fragment of a specific antibody was developed.

282 ogic features of ABMR were present but donor-specific antibody was undetected (49.4% [43/87]).

283 MAP20-specific antibody was used to study expression and local

284 Using specific antibodies, we now show that both nesprin-1-alp

285 A (n = 116), seropositivity rates for strain-specific antibodies were 44.0% (95% confidence interval

286 Influenza- and pertussis-specific antibodies were actively transferred.

287 rminal centres and the production of antigen-specific antibodies were compromised.

288 Serum concentrations of GBS III CPS-specific antibodies were determined using enzyme-linked

289 rotein-boosted regimens, half-lives of gp120-specific antibodies were longer but peak magnitudes were

290 VV-specific antibodies were maintained indefinitely among H

291 Vaccinia-specific antibodies were measured by ELISA.

292 VV-specific antibodies were measured by means of enzyme-lin

293 The H1N1pdm09-specific antibodies were measured by the hemagglutinatio

294 Specific antibodies were then functionalized on the PCA/

295 dney transplant or abrupt increases in donor-specific antibodies when biopsy cannot be performed for

296 e observed a significant increase in antigen-specific antibodies when we applied patches with TJ-disr

297 ion of mice with ZIKV E dimers induces dimer-specific antibodies, which protect against ZIKV challeng

298 g, a chromatin protein is bound in situ by a specific antibody, which then tethers a protein A-Tn5 tr

299 Nevertheless, rare but recurring RBD-specific antibodies with potent antiviral activity were

300 h GlcNAc on each glycosite induced more stem-specific antibodies, with higher antibody-dependent cell